IgA Hevylite® Test As a Surrogate to Serum Protein Electrophoresis (SPEP) or Nephelometry in the Management of IgA Myeloma
Eileen M. Boyle(BMW (Germany)), Xavier Leleu(Inserm), Philip Young, Thierry Façon(Université de Lille), Sarah Bonnet(Hôpital Saint Eloi), Salomon Manier(Université de Lille), Charles Herbaux(Centre Hospitalier Universitaire de Lille), Houria Debarri(Centre Hospitalier Universitaire de Lille), Julie Gay(Centre Hospitalier de la Côte Basque), Annie Pietrantuono, Bernadette Hennache(Université de Lille), Rémy Duléry(Dana-Farber Cancer Institute), Frederic Combat, Brigitte Onraed, Jean‐Luc Faucompré(Université de Lille), Stephen J. Harding, Hélène Demarquette(Ikerbasque)
Cited by 1
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
|Nature Communications|2014|906
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695